Tioga Pharmaceuticals, Inc.
Records under this name other than the patents Tioga Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 9 of 9 · Back to Tioga Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,344,566 | Method for producing enantiomer-free N-methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrolidine-1-yl)ethyl]-2,2-diphenylacetamide Term ended Term ended Jan 26, 2021 · USPTO record | Term ended | Term ended Jan 26, 2021 | USPTO record |
| US 7,385,065 | Derivatives of asimadoline with covalently bonded acids Lapsed on the fee record Ended Jun 10, 2020 · USPTO record | Lapsed on the fee record | Ended Jun 10, 2020 | USPTO record |
| US 7,960,429 | Kappa-opiate agonists for the treatment of diarrhea-predominant irritable bowel syndrome Lapsed on the fee record Ended Jun 14, 2019 · USPTO record | Lapsed on the fee record | Ended Jun 14, 2019 | USPTO record |
| US 8,877,800 | Kappa-opiate agonists for the treatment of diarrhea-predominant irritable bowel syndrome Lapsed on the fee record Ended Nov 4, 2018 · USPTO record | Lapsed on the fee record | Ended Nov 4, 2018 | USPTO record |
| US 6,060,504 | N-methyl-N-[(1S)-1-phenyl-2-(3S)-hydroxypyrrolidin-1-yl)ethyl]-2 -2-diphenylacetamide Term ended Term ended Aug 26, 2016 · USPTO record | Term ended | Term ended Aug 26, 2016 | USPTO record |
| US 7,915,228 | Derivatives of asimadoline with covalently bonded acids Formerly held Lapsed on the fee record Ended Mar 29, 2015 · USPTO record | Lapsed on the fee record | Ended Mar 29, 2015 | USPTO record |
| US 5,532,266 | Acrylacetamides Term ended Term ended no later than Jul 2, 2016 · Low confidence | Term ended | Term ended no later than Jul 2, 2016 | Low confidence |
| US 5,776,972 | Kappa-opiate agonists for inflammatory bowel disorders Term ended Term ended no later than Jul 7, 2018 · Low confidence | Term ended | Term ended no later than Jul 7, 2018 | Low confidence |
| US 5,977,161 | Kappa-opiate agonists effective in the treatment of postoperative ileus Formerly held Term ended Term ended no later than Nov 2, 2019 · Low confidence | Term ended | Term ended no later than Nov 2, 2019 | Low confidence |